Crohn’s and Colitis Canada is Proud to Announce the 2020 AbbVie IBD Scholarship Recipients

Crohn’s and Colitis Canada is Proud to Announce the 2020 AbbVie IBD Scholarship Recipients

TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Crohn’s and Colitis Canada awards 10 post-secondary students living with Crohn’s disease or ulcerative colitis with a one-time AbbVie IBD Scholarship, valued at $5,000, as they head back to class for the fall 2020 semester at a Canadian post-secondary institution. Recipients of the scholarship awarded through the AbbVie IBD Scholarship Program strive to maintain an optimal level of wellness while actively driving change in their communities, demonstrating academic aspiration, and inspiring their peers to fulfill their potential.
Crohn’s disease and ulcerative colitis (the two main forms of inflammatory bowel disease) are lifelong diseases that can be diagnosed at any age, but the typical age of onset is adolescence or early adulthood, the critical years for schooling and career growth. When someone develops one of these autoimmune diseases, their body begins to attack healthy tissue in their bowels, resulting in inflammation of all or part of the gastrointestinal tract. While each individual case is unique, severe abdominal pain, nausea, fatigue, internal bleeding, and the unpredictable and urgent need to use the washroom are the most common symptoms. There are no known cures for Crohn’s or colitis. If gone untreated, long-term consequences may lead to malnutrition, higher risk of cancer, and life-threatening complications.“The recipients of the AbbVie IBD Scholarship are resilient, ambitious, and motivated individuals – true leaders in their communities. Living with Crohn’s disease or ulcerative colitis can be stressful and disruptive to day-to-day life, affecting the ability to attend class or work to pay for post-secondary education. While studying and making a difference in their communities, these individuals have overcome the challenges that often come with these invisible diseases. They are an inspiration to all of us, demonstrating you can thrive and achieve your goals if you set your mind to it,” said Mina Mawani, President and CEO of Crohn’s and Colitis Canada. “We’re proud to collaborate with patient-focused partners like AbbVie to highlight the accomplishments and stories of these bright and inspirational individuals, and to support them in bringing their academic and career goals to fruition.”Since 2012, the AbbVie IBD Scholarship Program, made possible by an educational grant provided by AbbVie Canada, has awarded one-time $5,000 scholarships to 89 students living with Crohn’s disease or ulcerative colitis. To date, the program’s total financial contribution sits at $445,000. “Too many students with Crohn’s disease or ulcerative colitis are forced to delay completing post-secondary education as a result of their disease,” said Denis Hello, Vice President and General Manager of AbbVie Canada. “We’re proud to partner with Crohn’s and Colitis Canada on this worthy initiative, as we hope it will ease some of the financial burden on young Canadians with IBD so they can focus on their studies and live their lives to the fullest.”Crohn’s and Colitis Canada congratulates the 2020 AbbVie IBD Scholarship recipients: Ann Weber – University of ManitobaCarlie Thompson – Concordia UniversityDavid Pugh – York UniversityDennis Drewnik – University of ManitobaIsabelle Rochette – Université de MontréalKate Latos – University of AlbertaLisa MacNeil – Acadia UniversitySimona Perrotti – McMaster UniversitySophie LeBlanc – University of New BrunswickVanessa Reali – University of TorontoTo learn more about the AbbVie IBD Scholarship program and the 2020 scholarship recipients, please visit ibdscholarship.ca.About Crohn’s and Colitis CanadaAbout AbbVieWe’re a company that takes on the toughest health challenges.AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.ca and www.abbvie.com. Follow @abbviecanada on Twitter or find us on Facebook, LinkedIn and Instagram.For further information or to arrange interviews, please contact:Stacey Sheehan
Marketing and Communications Coordinator
Crohn’s and Colitis Canada
416-920-5035 ext. 243
ssheehan@crohnsandcolitis.ca
Gabrielle Poirier
Account Coordinator
Smithcom Limited
905-269-1127
gabrielle.poirier@smithcom.ca


CBJ Newsmakers

Recommended
DIAGNOS Receives $2,000,000 Assistance from QuebecSparton Resources Inc